KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
This Quarter Return
-2.49%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$302M
AUM Growth
+$302M
Cap. Flow
+$22.1M
Cap. Flow %
7.32%
Top 10 Hldgs %
96.77%
Holding
14
New
1
Increased
7
Reduced
6
Closed
–

Top Buys

1
EMBC icon
Embecta
EMBC
$25.8M
2
CAH icon
Cardinal Health
CAH
$8.66M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
$3.59M
4
BIIB icon
Biogen
BIIB
$1.2M
5
KOD icon
Kodiak Sciences
KOD
$791K

Top Sells

1
MCK icon
McKesson
MCK
$13.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
$3.84M
3
ALKS icon
Alkermes
ALKS
$776K
4
EXEL icon
Exelixis
EXEL
$490K
5
UTHR icon
United Therapeutics
UTHR
$90.5K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$13.8B
$47.4M 15.68% 201,228 -384 -0.2% -$90.5K
ALKS icon
2
Alkermes
ALKS
$4.78B
$41.7M 13.77% 1,398,159 -26,045 -2% -$776K
REGN icon
3
Regeneron Pharmaceuticals
REGN
$61.5B
$35.7M 11.8% 60,384 -6,496 -10% -$3.84M
EXEL icon
4
Exelixis
EXEL
$10.1B
$31.4M 10.37% 1,506,885 -23,521 -2% -$490K
ENTA icon
5
Enanta Pharmaceuticals
ENTA
$180M
$29.5M 9.76% 624,768 +75,940 +14% +$3.59M
MCK icon
6
McKesson
MCK
$85.4B
$27M 8.94% 82,894 -41,271 -33% -$13.5M
EMBC icon
7
Embecta
EMBC
$847M
$25.8M 8.51% +1,017,194 New +$25.8M
BIIB icon
8
Biogen
BIIB
$19.4B
$23.9M 7.9% 117,248 +5,895 +5% +$1.2M
TARO
9
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$21M 6.94% 580,524 +14,573 +3% +$527K
CAH icon
10
Cardinal Health
CAH
$35.5B
$9.35M 3.09% 178,839 +165,639 +1,255% +$8.66M
EGRX
11
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$5.38M 1.78% 121,014 +6,227 +5% +$277K
KOD icon
12
Kodiak Sciences
KOD
$478M
$4.23M 1.4% 554,192 +103,592 +23% +$791K
NXTC icon
13
NextCure
NXTC
$13.5M
$146K 0.05% 30,999 +408 +1% +$1.92K
ASMB icon
14
Assembly Biosciences
ASMB
$190M
$21K 0.01% 9,985 -115 -1% -$242